Fig. 1 · Structure
Documents & Downloads
(8β)-N,N,6-Triethyl-9,10-didehydro-1-(1-oxopropyl)ergoline-8-carboxamide
Drug Derivative Control
(8β)-N,N,6-Triethyl-9,10-didehydro-1-(1-oxopropyl)ergoline-8-carboxamide is a lysergamide derivative that acts primarily on serotonin receptors. This compound exhibits significant biological activity, influencing neurochemical pathways linked to mood and cognition. It is commonly utilized in research settings to investigate the pharmacological effects of lysergamide analogs and their potential therapeutic applications in neurological disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2230715-45-2 |
| Applications | Drug Derivative Control |
| Formula | C24H31N3O2 |
| Molecular Weight | 393.52 |
| SMILES | [H][C@]1(C2)N(C[C@@H](C=C1C3=CC=CC4=C3C2=CN4C(CC)=O)C(N(CC)CC)=O)CC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.